Insmed Inc. buy Truist Financial Co.
Start price
12.08.24
/
50%
€67.50
Target price
12.08.25
€77.77
Performance (%)
-2.22%
Price
16.09.24
€64.50
Summary
This prediction is currently active. With a performance of -2.22%, the BUY prediction for Insmed Inc. by Truist_Financial_Co_ is down slightly. This prediction currently runs until 12.08.25. The prediction end date can be changed by Truist_Financial_Co_ at any time. Truist_Financial_Co_ has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Insmed Inc. | -0.769% | -0.769% |
iShares Core DAX® | 1.195% | 2.111% |
iShares Nasdaq 100 | 3.220% | -1.375% |
iShares Nikkei 225® | 1.858% | 0.888% |
iShares S&P 500 | 2.168% | 0.612% |
Comments by Truist_Financial_Co_ for this prediction
In the thread Insmed Inc. diskutieren
Insmed Incorporated (NASDAQ: INSM) had its price target lowered by analysts at Truist Financial Co. from $88.00 to $85.00. They now have a "buy" rating on the stock.
Ratings data for INSM provided by MarketBeat